Concepedia

Shan-chun Wang

SW

Statistics

Publications

6

Citations

300

H-Index

6

Active since

2013

Affiliations

Nanjing University(Current)

First Affiliated Hospital of Guangzhou Medical University

Guangzhou Medical University

China Pharmaceutical University

Guangzhou Institutes of Biomedicine and Health

Shan-chun Wang is an author at Nanjing University specializing in pharmacology, fructose-induced liver injury, and drug discovery.

Publications per year

2013–2021

6

Publications

6

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

Ying Cheng, Qiming Wang, Kai Li et al. · British Journal of Cancer · 2021 · 147 citations · Full text

, , +9

Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling

Xiaojuan Zhao, Hongjiang Xu, Shan-chun Wang et al. · Acta Pharmacologica Sinica · 2018 · 61 citations · Full text

, , +12

Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1

Tushuai Li, Li Chen, Shan-chun Wang et al. · Biochemical Pharmacology · 2019 · 38 citations

, , +13

Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization

Hui Xie, Lili Zeng, Shaogao Zeng et al. · European Journal of Medicinal Chemistry · 2013 · 20 citations · Full text

, , +13

Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs

Shan-chun Wang, Xiquan Zhang, Hongjiang Xu et al. · European Journal of Pharmacology · 2020 · 18 citations

, , +15

1–5 of 6